Transurethral resection for bladder cancer using 5-aminolevulinic acid induced fluorescence endoscopy versus white light endoscopy

Journal of Urology

Volumn 168, Issue 2, 2002, Pages 475-478

  Kriegmair, Martin ^a,b   Zaak, Dirk ^a,b   Rothenberger, Karl Heinz ^a,b   Rassweiler, Jens ^a,b   Jocham, Dieter ^a,b   Eisenberger, Ferdinand ^a,b   Tauber, Roland ^a,b   Stenzl, Arnulf ^a,b   Hofstetter, Alfons ^a,b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b NONE

Author keywords

Bladder; Bladder neoplasms; Endoscopy; Fluorescence; Light

Indexed keywords

AMINOLEVULINIC ACID;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER SURGERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOSCOPY; FEMALE; FLUORESCENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION;

EID: 0036071722     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)64661-7     Document Type: Article

References (28)

1. The natural history of bladder cancer
2. Surgical management of noninvasive bladder cancer (stages Ta/T1/CIS)
3. Serial multiple-site biopsies in patients with bladder cancer
4. Der wert der transurethralen nachresektion beim oberflächlichen harnblasenkarzinom
5. Residual tumor discovered in routine second transurethral resection in patients with stage T1 transitional cell carcinoma of the bladder
6. Prospective study for quality control of TUR of bladder tumors by routine 2nd TUR (ReTUR)
7. Transurethral resection and surveillance of bladder cancer supported by 5-aminolevulinic acid-induced fluorescence endoscopy
8. Endoscopic detection of transitional cell carcinoma with 5-aminolevulinic acid: Results of 1012 fluorescence endoscopies
9. Intravesical adjuvant chemotherapy for superficial transitional cell bladder carcinoma: Results of 2 European Organization for Research and Treatment of Cancer randomized trials with mitomycin C and doxorubicin comparing early versus delayed instillations and short-term versus long-term treatment
10. Factors affecting recurrence and progression in superficial bladder tumors
11. Surgical techniques in the management of patients with superficial bladder cancer
12. Immediate adjuvant intravesical chemotherapy after transurethral resection of the bladder
13. Superficial bladder tumors (stage pTa grades 1 and 2): The importance of recurrence pattern following initial resection
14. Factors influencing the survival of patients with transitional cell tumours of the urinary bladder
15. Variability in the three-months recurrence rate after TUR in superficial transitional cell carcinoma (TCC) of the bladder: A combined analysis of 8 EORTC studies
16. Ultraviolet cystoscopy in patients with bladder cancer
17. Fluorescence diagnosis of porphyrin-marked urothelial tumors. Status of experimental development
18. Fluorescein angiography of the bladder: Technique and relevance to bladder cancer and interstitial cystitis patients
19. Value of in vivo mucosastaining test with methylene blue in the diagnosis of pretumoral and tumoral lesions of the bladder
20. Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid
21. Fluorescence cystoscopy following intravesical instillation of 5-aminolevulinic acid: A new procedure with high sensitivity for detection of hardly visible urothelial neoplasias
22. Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence
23. Clinical evaluation of a method for detecting superficial surgical transitional cell carcinoma of the bladder by light-induced fluorescence of protoporphyrin IX following the topical application of 5-aminolevulinic acid: Preliminary results
24. Clinical results of the transurethral resection and evaluation of superficial bladder carcinomas by means of fluorescence diagnosis after intravesical instillation of 5-aminolaevulinic acid
25. Diagnosis of bladder carcinoma using proroporhyrin IX fluoresence induced by 5-aminolaevulinic acid
26. Role of 5-aminolevulinic acid in the diagnosis and treatment of superficial bladder cancer: Improvement in diagnostic sensitivity
27. Should random urothelial biopsies be taken from patients with primary superficial bladder cancer? A decision analysis
28. Fluorescence endoscopy with 5-aminolevulinic acid reduces early recurrence rate in superficial bladder cancer